A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive Aspergillosis

Stopped An alternative joint industry effort will provide information on combination versus single agent therapy for treatment of aspergillosis

Conditions

• Aspergillosis/Blood
• Aspergillosis/Invasive

Interventions

• DRUG: micafungin
• DRUG: voriconazole

Sponsor

Astellas Pharma Inc